Received Feb 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
fever; itching; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On 06-FEB-2025, the patient received Shingles vaccine. In FEB-2025, an unknown time after receiving Shingles vaccine, the patient experienced fever (Verbatim: fever) and pruritus (Verbatim: itching). The outcome of the fever and pruritus were not reported. It was unknown if the reporter considered the fever and pruritus to be related to Shingles vaccine. It was unknown if the company considered the fever and pruritus to be related to Shingles vaccine. Additional Information: GSK receipt date: 07-FEB-2025 This case was reported by a patient via interactive digital media. The reporter reported that he/she had received Shingles vaccine day before reporting and wanted to know why it was itching with a fever around it.